Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Schlosser Michael J 2. Date of Event Requiring Statement (Month/Day/Year) 09/01/2026 3. Issuer Name and Ticker or Trading Symbol HCA Healthcare, Inc. [HCA] (Last) (First) (Middle) ONE PARK PLAZA 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP and Chief Clinical Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) NASHVILLE, TN 37203 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 170.1027(1) D Common Stock 6,951 I By 2022 Trust

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	(2)	02/01/2027	Common Stock	3,030	$81.96	D
Stock Appreciation Right	(3)	05/03/2027	Common Stock	1,898	$82.85	D
Stock Appreciation Right	(4)	01/31/2028	Common Stock	6,290	$101.16	D
Stock Appreciation Right	(5)	01/30/2029	Common Stock	4,400	$139.06	D
Stock Appreciation Right	(6)	01/29/2030	Common Stock	2,420	$145.24	D
Stock Appreciation Right	(7)	02/03/2031	Common Stock	2,100	$173.12	D
Stock Appreciation Right	(8)	07/22/2031	Common Stock	2,370	$246.79	D
Stock Appreciation Right	(9)	01/28/2032	Common Stock	4,160	$236.61	D
Stock Appreciation Right	(10)	01/30/2033	Common Stock	3,789	$253.3	D
Stock Appreciation Right	(11)	01/31/2034	Common Stock	3,577	$304.9	D
Stock Appreciation Right	(12)	01/28/2035	Common Stock	3,575	$328.7	D
Stock Appreciation Right	(13)	01/29/2036	Common Stock	3,103	$482.53	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Schlosser Michael J ONE PARK PLAZA NASHVILLE, TN 37203			EVP and Chief Clinical Officer

Signatures

/s/ Kevin A. Ball, Attorney-in-Fact		09/11/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans.
(2)	The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
(3)	The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.
(4)	The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
(5)	The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.
(6)	The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.
(7)	The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.
(8)	The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022.
(9)	The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.
(10)	The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.
(11)	The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.
(12)	The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.
(13)	The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.